BlackRock’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

BlackRock’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-676,740	Closed	-$16.5M	–	5087
2017 Q4	$16.5M	Buy	676,740 +64,681	+11%	+$1.24M	﹤0.01%	2879
2017 Q3	$11.3M	Buy	612,059 +21,984	+4%	+$381K	﹤0.01%	3098
2017 Q2	$9.77M	Buy	590,075 +159,593	+37%	+$2.22M	﹤0.01%	3184
2017 Q1	$5.94M	Buy	430,482 +430,038	+96,855%	+$6.9M	﹤0.01%	3332
2016 Q4	$8K	Sell	444 -74	-14%	-$1.42K	﹤0.01%	3452
2016 Q3	$11K	Buy	518 +172	+50%	+$3.23K	﹤0.01%	3392
2016 Q2	$6K	Buy	346 +270	+355%	+$4.65K	﹤0.01%	3503
2016 Q1	$1K	Buy	+76	New	+$1.23K	﹤0.01%	3614

BlackRock's ENTL Position: Q1 2018 in Review

BlackRock sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 676,740 shares — an estimated $16.5M sold.

BlackRock first reported a position in ENTL in Q1 2016 and held it in 8 quarters. The position peaked at $16.5M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

BlackRock reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
BlackRock sold 676,740 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $16.5M.
BlackRock first reported a position in Entellus Medical, Inc. Common Stock in Q1 2016 and held it in 8 quarters.
BlackRock's Entellus Medical, Inc. Common Stock position peaked at $16.5M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on BlackRock's 13F filing for Q1 2018, filed 9 May 2018.